EXECUTIVE ENGAGEMENTS
OUTREACH
INTERACTIONS
PARTICIPANTS
VALIDATIONS
* Login for a full stack data experience
DATE
JUL 2020
TABLES
60
PAGES
131
EDITION
7
PRICE
USD $4950
Tapping into New Geographical Markets is a Great Way to Grow!
What's Your Addressable Opportunity in the Cancer Cachexia Market?
SELECT PLAYERS
Aeterna Zentaris, Inc.; Alder BioPharmaceuticals, Inc.; Aphios Corporation; Bristol-Myers Squibb Company; Eli Lilly and Company; GTx, Inc.; Helsinn Healthcare SA; Merck & Co., Inc.; Novartis AG; XBiotech Inc.
SEGMENTS
» Therapeutics (Progestogens, Corticosteroids, Combination Therapies, Other Therapeutics)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
KEY DIFFERENTIATORS
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
INSIDER ACCESS PRIVILEGES
| I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Global Competitor Market Shares |
| Cancer Cachexia Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| Cancer Cachexia Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025 |
| Cancer Cachexia Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2009-2017 |
| Cancer Cachexia Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025 |
| Progestogens (Therapeutics) World Market by Region/Country in US$ Thousand: 2018 to 2025 |
| Progestogens (Therapeutics) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017 |
| Progestogens (Therapeutics) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025 |
| Corticosteroids (Therapeutics) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025 |
| Corticosteroids (Therapeutics) Historic Market Perspective by Region/Country in US$ Thousand: 2009 to 2017 |
| Corticosteroids (Therapeutics) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025 |
| Combination Therapies (Therapeutics) Geographic Market Spread Worldwide in US$ Thousand: 2018 to 2025 |
| Combination Therapies (Therapeutics) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2009 to 2017 |
| Combination Therapies (Therapeutics) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 |
| Other Therapeutics (Therapeutics) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2018 to 2025 |
| Other Therapeutics (Therapeutics) Market Historic Review by Region/Country in US$ Thousand: 2009 to 2017 |
| Other Therapeutics (Therapeutics) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025 |
| III. MARKET ANALYSIS |
| GEOGRAPHIC MARKET ANALYSIS |
| UNITED STATES |
| Market Facts & Figures |
| US Cancer Cachexia Market Share (in %) by Company: 2019 & 2025 |
| United States Cancer Cachexia Market Estimates and Projections in US$ Thousand by Therapeutics: 2018 to 2025 |
| Cancer Cachexia Market in the United States by Therapeutics: A Historic Review in US$ Thousand for 2009-2017 |
| United States Cancer Cachexia Market Share Breakdown by Therapeutics: 2009 VS 2019 VS 2025 |
| CANADA |
| Canadian Cancer Cachexia Market Estimates and Forecasts in US$ Thousand by Therapeutics: 2018 to 2025 |
| Canadian Cancer Cachexia Historic Market Review by Therapeutics in US$ Thousand: 2009-2017 |
| Cancer Cachexia Market in Canada: Percentage Share Breakdown of Sales by Therapeutics for 2009, 2019, and 2025 |
| JAPAN |
| Japanese Market for Cancer Cachexia: Annual Sales Estimates and Projections in US$ Thousand by Therapeutics for the Period 2018-2025 |
| Cancer Cachexia Market in Japan: Historic Sales Analysis in US$ Thousand by Therapeutics for the Period 2009-2017 |
| Japanese Cancer Cachexia Market Share Analysis by Therapeutics: 2009 VS 2019 VS 2025 |
| CHINA |
| Chinese Cancer Cachexia Market Growth Prospects in US$ Thousand by Therapeutics for the Period 2018-2025 |
| Cancer Cachexia Historic Market Analysis in China in US$ Thousand by Therapeutics: 2009-2017 |
| Chinese Cancer Cachexia Market by Therapeutics: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| EUROPE |
| Market Facts & Figures |
| European Cancer Cachexia Market: Competitor Market Share Scenario (in %) for 2019 & 2025 |
| European Cancer Cachexia Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025 |
| Cancer Cachexia Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2009-2017 |
| European Cancer Cachexia Market Share Shift by Region/Country: 2009 VS 2019 VS 2025 |
| European Cancer Cachexia Market Estimates and Forecasts in US$ Thousand by Therapeutics: 2018-2025 |
| Cancer Cachexia Market in Europe in US$ Thousand by Therapeutics: A Historic Review for the Period 2009-2017 |
| European Cancer Cachexia Market Share Breakdown by Therapeutics: 2009 VS 2019 VS 2025 |
| FRANCE |
| Cancer Cachexia Market in France by Therapeutics: Estimates and Projections in US$ Thousand for the Period 2018-2025 |
| French Cancer Cachexia Historic Market Scenario in US$ Thousand by Therapeutics: 2009-2017 |
| French Cancer Cachexia Market Share Analysis by Therapeutics: 2009 VS 2019 VS 2025 |
| GERMANY |
| Cancer Cachexia Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Therapeutics for the Period 2018-2025 |
| German Cancer Cachexia Historic Market Analysis in US$ Thousand by Therapeutics: 2009-2017 |
| German Cancer Cachexia Market Share Breakdown by Therapeutics: 2009 VS 2019 VS 2025 |
| ITALY |
| Italian Cancer Cachexia Market Growth Prospects in US$ Thousand by Therapeutics for the Period 2018-2025 |
| Cancer Cachexia Historic Market Analysis in Italy in US$ Thousand by Therapeutics: 2009-2017 |
| Italian Cancer Cachexia Market by Therapeutics: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| UNITED KINGDOM |
| United Kingdom Market for Cancer Cachexia: Annual Sales Estimates and Projections in US$ Thousand by Therapeutics for the Period 2018-2025 |
| Cancer Cachexia Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Therapeutics for the Period 2009-2017 |
| United Kingdom Cancer Cachexia Market Share Analysis by Therapeutics: 2009 VS 2019 VS 2025 |
| REST OF EUROPE |
| Rest of Europe Cancer Cachexia Market Estimates and Forecasts in US$ Thousand by Therapeutics: 2018-2025 |
| Cancer Cachexia Market in Rest of Europe in US$ Thousand by Therapeutics: A Historic Review for the Period 2009-2017 |
| Rest of Europe Cancer Cachexia Market Share Breakdown by Therapeutics: 2009 VS 2019 VS 2025 |
| ASIA-PACIFIC |
| Cancer Cachexia Market in Asia-Pacific by Therapeutics: Estimates and Projections in US$ Thousand for the Period 2018-2025 |
| Asia-Pacific Cancer Cachexia Historic Market Scenario in US$ Thousand by Therapeutics: 2009-2017 |
| Asia-Pacific Cancer Cachexia Market Share Analysis by Therapeutics: 2009 VS 2019 VS 2025 |
| REST OF WORLD |
| Rest of World Cancer Cachexia Market Estimates and Forecasts in US$ Thousand by Therapeutics: 2018 to 2025 |
| Rest of World Cancer Cachexia Historic Market Review by Therapeutics in US$ Thousand: 2009-2017 |
| Cancer Cachexia Market in Rest of World: Percentage Share Breakdown of Sales by Therapeutics for 2009, 2019, and 2025 |
| IV. COMPETITION |
| Total Companies Profiled : 41 Click here to request a full table of contents and more details on this project. |
| V. CURATED RESEARCH |
KEY DIFFERENTIATORS
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
RESEARCH PANEL
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.
- Complimentary previews of full stack research data for participated
- Insider access to research programs including engagements and stats from other panelists
- Unlimited research credits of $1000 per participated project
- Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
- Interact with other panelists via our MarketGlassTM Data Exchange Platform*
- BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*
* Complete details will be shared with panelists upon formal acceptance.